🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

11+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 11 of 11 recruiting trials for “Achondroplasia”

RecruitingNCT07388966 ↗

Prospective Longitudinal Monocentric Study to Measure Limb Movement in Patients With FGFR3-related Skeletal Dysplasia

👨‍⚕️ Genevieve Baujat, Hopital Necker📍 1 site📅 Started Feb 2026View details ↗
Phase 2RecruitingNCT07169279 ↗

Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)

🏥 QED Therapeutics, a BridgeBio company📍 13 sites📅 Started Nov 2025View details ↗
RecruitingNCT07301463 ↗

A Study in Children With Achondroplasia

👨‍⚕️ Yuan Lu, 12B, Building 1, No 515, Huanke Road, Pudong New Area, Shanghai 201210, China📍 8 sites📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06842355 ↗

A Study of TYRA-300 in Children With Achondroplasia: BEACH301

👨‍⚕️ Doug Warner, MD, Tyra Biosciences📍 13 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06732895 ↗

A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide in Adolescents (12 - 18 Years of Age) With Achondroplasia.

👨‍⚕️ Medical Director, MD, Ascendis Pharma A/S📍 5 sites📅 Started Dec 2024View details ↗
Phase 3RecruitingNCT06926491 ↗

Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study）

👨‍⚕️ Yu Sato, Kyowa Kirin Co., Ltd.📍 9 sites📅 Started Dec 2024View details ↗
Phase 2RecruitingNCT06079398 ↗

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With Achondroplasia

👨‍⚕️ Medical Director, MD, Ascendis Pharma A/S📍 17 sites📅 Started Jan 2024View details ↗
Phase 2, PHASE3Enrolling by InvitationNCT05929807 ↗

A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia

👨‍⚕️ Claus Strange, Ascendis Pharma A/S📍 17 sites📅 Started Jun 2023View details ↗
RecruitingNCT06168201 ↗

VIrtual STudy in Achondroplasia for the US (VISTA)

👨‍⚕️ Medical Director, MD, BioMarin Pharmaceutical📍 7 sites📅 Started Feb 2023View details ↗
Phase 2Enrolling by InvitationNCT05145010 ↗

Extension Study of Infigratinib in Children With Achondroplasia (ACH)

👨‍⚕️ QED Therapeutics SVP, Clinical Development, QED Therapeutics📍 31 sites📅 Started Dec 2021View details ↗
RecruitingNCT05328050 ↗

Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)

🏥 Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico📍 1 site📅 Started Sep 2021View details ↗

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →